From Risk Reduction to Implementation: Addressing the Opioid Epidemic and Continued Challenges to Our Field

Case A , Deaton A . Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci U S A. 2015;112(49):15078–15083.

Centers for Disease Control and Prevention/National Center for Health Statistics. National Vital Statistics System, Mortality File.; 2015. Available at: http://www.cdc.gov/nchs/data/health_policy/AADR_drug_poisoning_involving_OA_Heroin_US_2000-2014.pdf. Number and age-adjusted rates of drug poisoning deaths involving opioid analgesics and heroin: United States, 2000-2014.

Rudd RA , Paulozzi LJ , Bauer MJ , . Increases in heroin overdose deaths—28 States, 2010 to 2012. MMWR Morb Mort Wkly Rep. 2014;63:849–854.

Calcaterra S , Glanz J , Binswanger IA . National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009. Drug Alcohol Depend. 2013;131:263–270.

Han B , Hedden SL , Lipari R , Copello EAP , Kroutil LA . Receipt of Services for Behavioral Health Problems: Results From the 2014 National Survey on Drug Use and Health. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015.

Gordon AJ , Jenkins JA . The time is now: the role of pharmacotherapies in expanding treatment for opioid use disorder. Subst Abus. 2015;36:127–128.

Oliva EM , Nevedal AL , Lewis ET , . Patient perspectives on an opioid overdose education and naloxone distribution program in the US Department of Veterans Affairs Subst Abus. 2016;37.

Winstanley EL , Clark A , Feinberg J , Wilder C . Barriers to implementation of opioid overdose prevention programs in Ohio. Subst Abus. 2016;37.

Ashrafioun L , Gamble S , Herrmann M , Baciewicz G . Evaluation of knowledge and confidence following opioid overdose prevention training: a comparison of types of training participants and naloxone administration methods. Subst Abus. 2016;37.

Haug NA , Bielenberg J , Linder SH , Lembke A . Assessment of provider attitudes toward #Naloxone on Twitter. Subst Abus. 2016;37.

Chou R , Turner JA , Devine EB , . The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162:276–286.

Morasco B , Peters D , Krebs E , Hart K , Kovas A , Dobscha S . Predictors of urine drug testing for patients with chronic pain: results from a national cohort of US veterans. Subst Abus. 2016;37.

McCauley JL , Leite RS , Melvin CL , Fillingim RB , Brady K . Dental opioid prescribing practices and risk mitigation strategy implementation: identification of potential targets for provider-level intervention. Subst Abus. 2016;37.

Bauer SR , Hitchner L , Harrison H , Gerstenberger J , Steiger S . Predictors of higher risk chronic opioid prescriptions in an academic primary care setting. Subst Abus. 2016;37.

Starrels J , Peyser D , Haughton L , . When HIV treatment goals conflict with guideline-based opioid prescribing: a qualitative study of HIV providers. Subst Abus. 2016;37.

Stumbo SP , Yarborough BJH , Janoff SL , Yarborough MT , McCarty D , Green CA . A qualitative analysis of family involvement in prescribed opioid medication monitoring among individuals who have experienced opioid overdoses. Subst Abus. 2016;37.

Broyles LM , Binswanger IA , Jenkins JA , . Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response. Subst Abus. 2014;35:217–221.